| 标题 |
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet 作者:Brad H. Rovin; Brad H Rovin; Jonathan Barratt; Hiddo J.L. Heerspink; Charles E. Alpers; et al 出版日期:2023-11-03 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)